These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24990894)

  • 1. Do large pores in the glomerular capillary wall account for albuminuria in nephrotic states?
    Vuchkova J; Koltun M; Greive K; Comper WD
    Am J Physiol Renal Physiol; 2014 Sep; 307(5):F525-32. PubMed ID: 24990894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular permselectivity factors are not responsible for the increase in fractional clearance of albumin in rat glomerulonephritis.
    Greive KA; Nikolic-Paterson DJ; Guimarães MA; Nikolovski J; Pratt LM; Mu W; Atkins RC; Comper WD
    Am J Pathol; 2001 Sep; 159(3):1159-70. PubMed ID: 11549609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules.
    Bohrer MP; Baylis C; Robertson CR; Brenner BM; Troy JL; Willis WT
    J Clin Invest; 1977 Jul; 60(1):152-61. PubMed ID: 874080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of size selectivity of the glomerular filtration barrier in rats following laparotomy and muscle trauma.
    Axelsson J; Mahmutovic I; Rippe A; Rippe B
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F577-82. PubMed ID: 19587143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anomalous fractional clearance of negatively charged Ficoll relative to uncharged Ficoll.
    Guimarães MA; Nikolovski J; Pratt LM; Greive K; Comper WD
    Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1118-24. PubMed ID: 12876070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal processing of serum proteins in an albumin-deficient environment: an in vivo study of glomerulonephritis in the Nagase analbuminaemic rat.
    Osicka TM; Strong KJ; Nikolic-Paterson DJ; Atkins RC; Jerums G; Comper WD
    Nephrol Dial Transplant; 2004 Feb; 19(2):320-8. PubMed ID: 14736954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Size-selectivity of the glomerular barrier to high molecular weight proteins: upper size limitations of shunt pathways.
    Tencer J; Frick IM; Oquist BW; Alm P; Rippe B
    Kidney Int; 1998 Mar; 53(3):709-15. PubMed ID: 9507218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis.
    Hjalmarsson C; Lidell ME; Haraldsson B
    Nephrol Dial Transplant; 2006 May; 21(5):1223-30. PubMed ID: 16410268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats.
    Olson JL; Rennke HG; Venkatachalam MA
    Lab Invest; 1981 Mar; 44(3):271-9. PubMed ID: 7464051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puromycin aminonucleoside damages the glomerular size barrier with minimal effects on charge density.
    Hjalmarsson C; Ohlson M; Haraldsson B
    Am J Physiol Renal Physiol; 2001 Sep; 281(3):F503-12. PubMed ID: 11502599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter to the Editor: "Can early plasma elimination rate be used to quantify renal clearance of macromolecules?".
    Öberg CM; Rippe B
    Am J Physiol Renal Physiol; 2015 Jan; 308(2):F164-5. PubMed ID: 25560050
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of hypoalbuminemia in rodents.
    Koltun M; Nikolovski J; Strong K; Nikolic-Paterson D; Comper WD
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1604-10. PubMed ID: 15539420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular permselectivity in early stages of overt diabetic nephropathy.
    Andersen S; Blouch K; Bialek J; Deckert M; Parving HH; Myers BD
    Kidney Int; 2000 Nov; 58(5):2129-37. PubMed ID: 11044234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR inhibition with temsirolimus causes acute increases in glomerular permeability, but inhibits the dynamic permeability actions of puromycin aminonucleoside.
    Axelsson J; Rippe A; Rippe B
    Am J Physiol Renal Physiol; 2015 May; 308(10):F1056-64. PubMed ID: 25740597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective albuminuria via podocyte albumin transport in puromycin nephrotic rats is attenuated by an inhibitor of NADPH oxidase.
    Kinugasa S; Tojo A; Sakai T; Tsumura H; Takahashi M; Hirata Y; Fujita T
    Kidney Int; 2011 Dec; 80(12):1328-38. PubMed ID: 21849973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Puromycin aminonucleoside nephrosis results in a marked increase in fractional clearance of albumin.
    Osicka TM; Hankin AR; Comper WD
    Am J Physiol; 1999 Jul; 277(1):F139-45. PubMed ID: 10409307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular configuration and glomerular size selectivity in healthy and nephrotic humans.
    Blouch K; Deen WM; Fauvel JP; Bialek J; Derby G; Myers BD
    Am J Physiol; 1997 Sep; 273(3 Pt 2):F430-7. PubMed ID: 9321916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular mesangium. Analysis of the increased activity observed in experimental acute aminonucleoside nephrosis in the rat.
    Grond J; Elema JD
    Lab Invest; 1981 Nov; 45(5):400-9. PubMed ID: 7300251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular albumin filtration through podocyte cell body in puromycin aminonucleoside nephrotic rat.
    Tojo A; Onozato ML; Kitiyakara C; Kinugasa S; Fukuda S; Sakai T; Fujita T
    Med Mol Morphol; 2008 Jun; 41(2):92-8. PubMed ID: 18592163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ultrastructural study of the glomerular slit diaphragm in aminonucleoside nephrosis.
    Ryan GB; Rodewald R; Karnovsky MJ
    Lab Invest; 1975 Nov; 33(5):461-8. PubMed ID: 1186127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.